SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cerner Corp – ‘10-Q’ for 9/30/17 – ‘EX-31.1’

On:  Friday, 10/27/17, at 4:02pm ET   ·   For:  9/30/17   ·   Accession #:  804753-17-39   ·   File #:  0-15386

Previous ‘10-Q’:  ‘10-Q’ on 7/28/17 for 7/1/17   ·   Next:  ‘10-Q’ on 5/3/18 for 3/31/18   ·   Latest:  ‘10-Q’ on 5/3/22 for 3/31/22   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/27/17  Cerner Corp                       10-Q        9/30/17   60:6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    535K 
 2: EX-10.1     Material Contract                                   HTML     80K 
 8: EX-10.10    Material Contract                                   HTML    148K 
 3: EX-10.2     Material Contract                                   HTML     30K 
 4: EX-10.3     Material Contract                                   HTML     35K 
 5: EX-10.4     Material Contract                                   HTML     36K 
 6: EX-10.5     Material Contract                                   HTML     43K 
 7: EX-10.6     Material Contract                                   HTML     35K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
10: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
12: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
19: R1          Document And Entity Information                     HTML     36K 
20: R2          Consolidated Balance Sheets                         HTML    105K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     25K 
22: R4          Consolidated Statements Of Operations               HTML     74K 
23: R5          Consolidated Statements Of Operations               HTML     20K 
                (Parenthetical)                                                  
24: R6          Consolidated Statements Of Comprehensive Income     HTML     31K 
25: R7          Consolidated Statements Of Comprehensive Income     HTML     22K 
                (Parenthetical)                                                  
26: R8          Consolidated Statements Of Cash Flows               HTML    101K 
27: R9          Interim Statement Presentation (Notes)              HTML     64K 
28: R10         Fair Value Measurements                             HTML     79K 
29: R11         Investments                                         HTML    120K 
30: R12         Receivables                                         HTML     39K 
31: R13         Income Taxes                                        HTML     21K 
32: R14         Earnings Per Share                                  HTML     87K 
33: R15         Share-Based Compensation                            HTML     88K 
34: R16         Contingencies                                       HTML     24K 
35: R17         Segment Reporting                                   HTML    124K 
36: R18         Fair Value Measurements (Tables)                    HTML     73K 
37: R19         Investments Investments (Tables)                    HTML    117K 
38: R20         Receivables (Tables)                                HTML     32K 
39: R21         Earnings Per Share (Tables)                         HTML     84K 
40: R22         Share-Based Compensation (Tables)                   HTML     91K 
41: R23         Segment Reporting (Tables)                          HTML    123K 
42: R24         Interim Statement Presentation Policies (Details)   HTML    111K 
43: R25         Fair Value Measurements (Narrative) (Details)       HTML     22K 
44: R26         Fair Value Measurements Fair Value, Assets and      HTML     43K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
45: R27         Investments (Narrative) (Details)                   HTML     19K 
46: R28         Investments (Details)                               HTML     52K 
47: R29         Receivables (Narrative) (Details)                   HTML     19K 
48: R30         Receivables (Summary Of Net Receivables) (Details)  HTML     31K 
49: R31         Income Taxes (Details)                              HTML     20K 
50: R32         Earnings Per Share (Reconciliation Of The           HTML     39K 
                Numerators And The Denominators Of The Basic And                 
                Diluted Per Share) (Details)                                     
51: R33         Earnings Per Share (Narrative) (Details)            HTML     25K 
52: R34         Share-Based Compensation (Schedule Of Stock         HTML     53K 
                Options Activity) (Details)                                      
53: R35         Share-Based Compensation (Schedule of Share-based   HTML     27K 
                Payment Award, Stock Options, Valuation                          
                Assumptions) (Details)                                           
54: R36         Share-Based Compensation (Schedule Of Non-Vested    HTML     40K 
                Shares Activity) (Details)                                       
55: R37         Share-Based Compensation (Compensation Expense      HTML     31K 
                Recognized In The Condensed Consolidated                         
                Statements Of Operations) (Details)                              
56: R38         Share-Based Compensation (Narrative) (Details)      HTML     38K 
57: R39         Segment Reporting (Summary Of The Operating         HTML     39K 
                Information) (Details)                                           
59: XML         IDEA XML File -- Filing Summary                      XML     90K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     51K 
13: EX-101.INS  XBRL Instance -- cern-20170930                       XML   1.54M 
15: EX-101.CAL  XBRL Calculations -- cern-20170930_cal               XML    149K 
16: EX-101.DEF  XBRL Definitions -- cern-20170930_def                XML    369K 
17: EX-101.LAB  XBRL Labels -- cern-20170930_lab                     XML    855K 
18: EX-101.PRE  XBRL Presentations -- cern-20170930_pre              XML    490K 
14: EX-101.SCH  XBRL Schema -- cern-20170930                         XSD     87K 
60: ZIP         XBRL Zipped Folder -- 0000804753-17-000039-xbrl      Zip    135K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 31.1
CERTIFICATION
I, Clifford W. Illig, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Cerner Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)         designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)         designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)         evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)         disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)         all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)         any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/s/Clifford W. Illig                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interim Chief Executive Officer
 
 
 
 
 
 
 
 
(Principal Executive Officer)
 
 



Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/27/17None on these Dates
For Period end:9/30/17
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/22  Cerner Corp.                      10-K       12/31/21  135:13M
 2/19/21  Cerner Corp.                      10-K       12/31/20  140:13M
Top
Filing Submission 0000804753-17-000039   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 6:24:38.1pm ET